Poland· PL-100367766
AulinDol
A nimesulide product containing nimesulidum, registered in Poland by Angelini Pharma Polska Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nimesulide is registered in 3 of 19 countries.
Countries holding a registration under ATC M02AA26 (nimesulide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Nimesulide · ATC M02AA26
3 / 19 countries
- Czechiaprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Nimesulidum
- Manufacturer
- Angelini Pharma Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M02AA26
- ATC class
- Nimesulide
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991276539
- gtin05909991276546
- gtin05909991276553
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nimesulide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAULINAngelini Pharma Česká republika s.r.o., Brno
- ItalyALGOLIDERSIAR PHARMA S.R.L.
- SwitzerlandAulin 100
- FinlandNimedHelsinn Birex Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Bulgaria · Aулин, Аулин
- Cyprus · Aponil, Elinap
- Czechia · Aulin, Coxtral
- Greece · Cliovyl, Dolostop
- Croatia · Dilmin
- Hungary · Mesulid, Nidol
- Italy · Actalide, Algolider
- Lithuania · Aponil, Nimesil
- Latvia · Aponil, Nimesil
- Malta · Remov
- Portugal · Aulin, Dolorilgel
- Romania · Aulin, Lemesil
- Slovakia · Aulin, Nimesil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7af34d8e-f3f2-4ffd-b3ec-38abefb29a42 GET /v1/drugs/7af34d8e-f3f2-4ffd-b3ec-38abefb29a42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "30 mg/g",
"packaging": "05909991276539 ¦ OTC ¦ 115885\n1 tuba 50 g\n05909991276546 ¦ OTC ¦ Skasowane ¦ 115886\n1 tuba 30 g\n05909991276553 ¦ OTC ¦ 115887\n1 tuba 100 g",
"substance": "Nimesulidum",
"common_name": "Nimesulidum",
"pl_product_id": "100367766",
"pozwolenie_nr": "23201",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about nimesulide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.